Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review

The Lancet Infectious Diseases

Volumn 8, Issue 12, 2008, Pages 777-784

  Planche, Tim ^a,b   Aghaizu, Adamma ^b   Holliman, Richard ^a,b   Riley, Peter ^a,b   Poloniecki, Jan ^b   Breathnach, Aodhán ^a,b   Krishna, Sanjeev ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

BACTERIAL INFECTION; BACTERIUM CULTURE; CELL CULTURE; CLOSTRIDIUM DIFFICILE; DIAGNOSTIC KIT; DIAGNOSTIC TEST; EPIDEMIC; FECES ANALYSIS; HUMAN; PREDICTION AND FORECASTING; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

BACTERIOLOGICAL TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ENTEROTOXINS; FECES; HUMANS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 56149107841     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(08)70233-0     Document Type: Review

References (41)

1. Bartlett J.G., and Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 46 suppl 1 (2008) S12-S18
2. Gerding D.N., Muto C.A., and Owens R.C. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 46 suppl 1 (2008) S43-S49
3. UK Department of Health. Changes to the mandatory healthcare associated infection surveillance system for Clostridium difficile infection (CDI) from 1st January 2008 [PL CMO (2008)1]. http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Pr ofessionalletters/Chiefmedicalofficerletters/DH_082107 (accessed Sept 3, 2008).
4. UK Department of Health. Mandatory surveillance of orthopaedic surgical site infection and C difficile associated diarrhoea (10 April 2008). http://www.dh.gov.uk/en/Publicationsandstatistics/Bulletins/theweek/Chie fexecutivebulletin/DH_4080306 (accessed Sept 3, 2008).
5. UK Parliament. Hansard daily report. Clostridium difficile. Statement by the Secretary of State for Health (Alan Johnson), 15 Oct 2007, column 557. http://www.publications.parliament.uk/pa/cm200607/cmhansrd/cm071015/debt ext/71015-0003.htm#0710153000484 (accessed Sept 3, 2008).
6. UK Department of Health. The standard NHS contract for acute hospital services (2007) [schedule 3, part 1, para 9]. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/Publicati onsPolicyAndGuidance/DH_081100 (accessed Sept 3, 2008).
7. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346 (2002) 334-339
8. Poutanen S.M., and Simor A.E. Clostridium difficile-associated diarrhea in adults. CMAJ 171 (2004) 51-58
9. George W.L., Sutter V.L., Citron D., and Finegold S.M. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 9 (1979) 214-219
10. van den Berg R.J., Vaessen N., Endtz H.P., Schulin T., van der Vorm E.R., and Kuijper E.J. Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J Med Microbiol 56 (2007) 36-42
11. Lemee L., Dhalluin A., Testelin S., et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 42 (2004) 5710-5714
12. Reyes R.C., John M.A., Ayotte D.L., Covacich A., Milburn S., and Hussain Z. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples. Diagn Microbiol Infect Dis 59 (2007) 33-37
13. Snell H., Ramos M., Longo S., John M., and Hussain Z. Performance of the TechLab C DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C difficile Tox A/B II EIA kit, the Triage C difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 42 (2004) 4863-4865
14. National Clostridium difficile Standards Group. Report to the Department of Health (February 2003). http://www.his.org.uk/_db/_documents/FINAL_C_diff_report.pdf (accessed Sept 3, 2008).
15. Health Protection Agency. Clostridium difficile infection: how to deal with the problem-a board to ward approach. http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1204186173 530?p=120 (accessed Sept 3, 2008).
16. Altman D.G., and Bland J.M. Diagnostic tests. 1: sensitivity and specificity. BMJ 308 (1994) 1552
17. Higgins J.P.T., and Green S. Cochrane handbook for systematic reviews of interventions 4.2.6 [updated September, 2006] (2006), John Wiley & Sons Ltd, Chichester
18. Glas A.S., Lijmer J.G., Prins M.H., Bonsel G.J., and Bossuyt P.M. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56 (2003) 1129-1135
19. Leeming J., Ferguson J., Kulpoo D., Kemp V., Watts J., and Carrington D. Comparison of methods of Clostridium difficile toxins. Clin Microbiol Infect 12 suppl 4 (2006) P1643
20. Miendje Y, Vandenberg O, Crockaert F, et al. Evaluation of three commercial tests for the rapid diagnosis of Clostridium difficile-mediated antibiotic-associated diarrhoea: a routine laboratory perspective. Proceedings of the 15th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark; April 2-5, 2005. Abstract 1134_03_71.
21. Benavente A, Andreu A, Juste C, Brazier J, Bartolome R. Evaluation of immunoassay methods for detection of Clostridium difficile toxins. Proceedings of the 12th European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy; April 24-27, 2002. Abstract P1526.
22. Gleaves C, Aldeen R, Schwarz K Campbell M, Carroll K. Evaluation of the Premier toxins A & B EIA for the detection of C difficile from clinical stool specimens. Proceedings of the American Society of Microbiology 100th General Meeting; Los Angeles, CA, USA; May 21-25, 2000. Abstract 30377.
23. Gleaves C, Vanderpool M, Ventrola C, Spencer S, Gorss E, Glover H. Clostridium difficile toxins A&B testing in a pediatric population-a multicenter study. Proceedings of the American Society of Microbiology 101st General Meeting; Orlando, FL, USA; May 20-24, 2001. Abstract 47627.
24. Summers A, Snow K, Dunham L, Craft D. Comparative evaluation of six commercially available assays for the detection of Clostridium difficile toxins in fecal specimens. Proceedings of the American Society of Microbiology 106th General Meeting; Orlando, FL, USA; May 21-25, 2006. Abstract 107876.
25. O'Connor D., Hynes P., Cormican M., Collins E., Corbett-Feeney G., and Cassidy M. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 39 (2001) 2846-2849
26. Musher D.M., Manhas A., Jain P., et al. Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J Clin Microbiol 45 (2007) 2737-2739
27. Massey V., Gregson D.B., Chagla A.H., Storey M., John M.A., and Hussain Z. Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea. Am J Clin Pathol 119 (2003) 45-49
28. Russmann H., Panthel K., Bader R.C., Schmitt C., and Schaumann R. Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens. Eur J Clin Microbiol Infect Dis 26 (2007) 115-119
29. Greene W. Comparison of the TOX A/B QUIK CHEK™ to tissue culture assay and to a commercial A+B ELISA for the detection of Clostridium difficile toxins in fecal specimens. Proceedings of the American Society of Microbiology 106th General Meeting; Orlando, FL, USA; May 21-25, 2006. Abstract 106767.
30. Van Broeck J, Verhaegen J, Van Kerkhoven D, Van Meensel B, Delmée M. Multicentre evaluation of a new rapid Tox A+B test (Meridian ICTAB) for the diagnosis of Clostridium difficile-associated diarrhoea. Proceedings of the 15th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark; April 2-5, 2005. Abstract 1134_03_72.
31. Berg RJ, Bruijnesteijn ES, Gerritsen HJ, Endtz HP, Vorm ER, Kuijper EJ. Rapid detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study, using a new immunoassay and real-time PCR. Proceedings of the 15th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark; April 2-5, 2005. Abstract 1133_172.
32. Sliwinski G, Turner D, Trout A, Kozak K. Detection of Clostridium difficile toxins A & B using a rapid enzyme immunoassay. Proceedings of the American Society of Microbiology 105th General Meeting; Atlanta, GA, USA; June 5-9, 2005. Abstract 97465.
33. Carricajo A, Vautrin AC, Fonsale N, Bastide MC, Foussadier A, Aubert G. Evaluation of the performance of the new VIDAS C difficile toxin A/B test. Proceedings of the 15th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark; April 2-5, 2005. Abstract 1134_03_265.
34. Barbut F., Delmee M., Brazier J.S., et al. A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 9 (2003) 989-996
35. van den Berg R.J., van Coppenraet L.B., Gerritsen H.J., Endtz H.P., van der Vorm E.R., and Kuijper E.J. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol 43 (2005) 5338-5340
36. Ticehurst J.R., Aird D.Z., Dam L.M., et al. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 44 (2006) 1145-1149
37. Alfa M.J., Swan B., VanDekerkhove B., Pang P., and Harding G.K. The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C difficile panel, EIA for Tox A/B and cytotoxin assays. Diagn Microbiol Infect Dis 43 (2002) 257-263
38. Hansen BE, Tang YJ, Cohen SH, Silva JJ, Carlson JR. A new algorithm for laboratory screening and confirmation of toxigenic Clostridium difficile. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, CA, USA; Sept 26-29, 1999. Abstract 1191.
39. Alcabasa R, Lema C, Reller M, Carroll K. Comparison of rapid assays for C difficile antigen (C. DIFF QUIK CHEK™ and C DIFF CHEK™) and C difficile toxin detection (TOX A/B QUIK CHEK®) to a cell culture neutralization assay. Proceedings of the American Society of Microbiology 107th General Meeting; Toronto, ON, Canada; May 21-25, 2007. Abstract 115207.
40. Lineback P, Reynolds J, Blue D, Allen S. Three-step algorithm to detect toxigenic Clostridium difficile in fecal samples using an enzyme immunoassay for glutamate dehydrogenase, an enzyme immunoassay for toxins A and B, and a third step using a cytotoxin neutralization assay, and culture for toxigenic C difficile. Proceedings of the American Society of Microbiology 107th General Meeting; Toronto, ON, Canada; May 21-25, 2007. Abstract 115208.
41. Fenner L., Widmer A.F., Goy G., Rudin S., and Frei R. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 46 (2008) 328-330